Skip to main content
. 2022 Dec 23;13(1):48. doi: 10.3390/diagnostics13010048

Table 1.

Increased Nuchal Translucency and Genetic Testing-systematic review.

Nuchal Translucency
Reference Dimension
(mm)
Association Yield (Incremental)
Karyotype CMA RASopathy Panel ES
[47] 2.5–2.9 unspecified 8/134
(5.97%)
3/126
(2.38%)
. .
3.0–3.4 unspecified 8/146
(5.48%)
2/138
(1.45%)
. .
3.5–4.4 unspecified 23/140
(16.43%)
7/117
(5.98%)
. .
4.5–5.4 unspecified 7/32
(21.88%)
0/25
(0.00%)
. .
5.5–6.4 unspecified 7/13
(53.85%)
1/6
(16.67%)
. .
≥6.5 unspecified 18/34
(52.94%)
2/16
(12.50%)
. .
[48] 3.0–3.4 unspecified 15/110
(13.64%)
3/60
(5.00%)
. .
3.5–4.4 unspecified 28/83
(33.74%)
3/37
(8.11%)
. .
4.5–5.4 unspecified 18/40
(45.00%)
1/40
(2.50%)
. .
5.5–6.4 unspecified 12/30
(40.00%)
. . .
6.5–7.4 unspecified 9/21
(42.86%)
. . .
≥7.5 unspecified 21/35
(60.00%)
. . .
≥4.5 unspecified 60/126
(47.62%)
1/40
(2.50%)
. .
[49] ≥3.5 apparently isolated . . 2/73
(2.74%)
2/71
(2.82%)
[50] ≥2.5 unspecified 18/192
(9.38%)
. . .
2.5–3.4 apparently isolated . 2/119
(1.68%)
. .
2.5–3.4 associated . 0/15
(0.00%)
. .
≥3.5 apparently isolated . 1/43
(2.33%)
. .
≥3.5 associated . 2/12
(16.67%)
. .
[51] ≥3.5 apparently isolated . 1/39
(2.56%)
. .
[52] ≥3.5 apparently isolated 134/362
(37.02%)
1/229
(0.44%)
. .
[14] ≥3.5 unspecified 123/226
(54.42%)
2/103
(1.94%)
3/103
(2.74%)
.
[53] 95ct–3.4 apparently isolated 18/114
(15.79%)
2/96
(2.01%)
. .
3.5–4.4 apparently isolated 30/150
(20.00%)
2/120
(1.67%)
. .
4.5–5.4 apparently isolated 16/55
(30.09%)
2/39
(5.13%)
. .
≥5.5 apparently isolated 29/55
(52.73%)
1/26
(3.85%)
1/22
(4.55%)
2/21
(9.52%)
[54] 3.0–3.4 apparently isolated 20/619
(32.31%)
9/599
(1.50%)
. .
[55] ≥3.5 unspecified 57/175
(32.57%)
3/118
(2.54%)
. .
[56] 2.5–3.4 unspecified 245/1372
(17.86%)
. . .
3.5–4.4 unspecified 182/866
(21.02%)
. . .
4.5–5.4 unspecified 77/282
(27.30%)
. . .
5.5–6.4 unspecified 29/109
(26.61%)
. . .
≥6.5 unspecified 27/91
(29.67%)
. . .
[57] ≥3.5 apparently isolated . . 0/111
(0.00%)
2/111
(1.80%)
≥3.5 associated . . 7/91
(7.69%)
17/84
(20.24%)
[58] 3.0–3.4 apparently isolated 8/170
(4.70%)
3/162
(1.85%)
. .
≥3.5 apparently isolated 16/138
(42.11%)
3/122
(2.46%)
. .
[50] 3.5–4.4 apparently isolated 16/76
(21.05%)
3/60
(5.00%)
. .
≥4.5 apparently isolated 27/56
(48.21%)
5/29
(17.24%)
. .
[60] 2.5–3.4 unspecified 7/57
(12.28%)
1/49
(2.94%)
. .
3.5–4.4 unspecified 10/39
(25.64%)
1/29
(3.45%)
. .
4.5–5.4 unspecified 7/19
(36.84%)
0/12
(0.00%)
. .
≥5.5 unspecified 13/24
(54.17%)
0/11
(0.00%)
. .
[61] 2.5–2.9 apparently isolated 10/86
(11.63%)
1/76
(1.32%)
. .
3.0–3.4 apparently isolated 11/73
(15.06%)
2/62
(3.23%)
. .
3.5–4.4 apparently isolated 9/50
(18.00%)
2/41
(4.88%)
. .
4.5–5.4 apparently isolated 10/21
(47.62%)
0/11
(0.00%)
. .
≥5.5 apparently isolated 7/11
(63.64%)
0/4
(0.00%)
. .
[62] ≥95ct unspecified 66/287
(23.00%)
. . .
[63] ≥3.5 unspecified 179/242
(73.96%)
. . .
[64] ≥95ct unspecified 119/541
(22.00%)
. . .
[65] ≥3.5 unspecified 16/71
(22.54%)
. . .
[66] ≥3.0 unspecified 6/105
(5.71%)
. . .
[67] ≥2.5 unspecified 18/122
(14.75%)
. . .
[68] ≥3 unspecified 224/1058
(21.17%)
. . .
3.0–3.4 unspecified 65/676
(9.62%)
. . .
3.5–4.4 unspecified 51/208
(24.52%)
. . .
4.5–5.4 unspecified 29/67
(43.28%)
. . .
5.5–6.4 unspecified 26/37
(70.27%)
. . .
≥6.5 unspecified 53/70
(75.71%)
. . .
[69] 95ct–3.4 unspecified 124/894
(13.87%)
8/770
(1.04%)
. .
≥3.5 unspecified 436/1007
(43.30%)
30/571
(5.25%)
. .
3.5–4.9 unspecified 138/492
(28.05%)
16/354
(4.52%)
. .
5.0–6.4 unspecified 113/199
(56.78%)
7/86
(8.14%)
. .
6.5–7.9 unspecified 93/155
(60.00%)
5/62
(8.06%)
. .
≥8.0 unspecified 92/162
(56.79%)
2/70
(2.86%)
. .
[101] ≥3 unspecified 10/120
(8.33%)
. . .
[70] 95ct–3.4 unspecified 40/263
(15.21%)
. . .
3.5–4.4 unspecified 32/169
(18.93%)
. . .
4.5–5.4 unspecified 37/79
(46.84%)
. . .
5.5–6.4 unspecified 33/52
(63.46%)
. . .
≥6.5 unspecified 55/85
(64.71%)
. . .
[71] ≥3.5 apparently isolated . 5/34
(14.70%)
. .
≥3.5 associated . 3/16
(18.75%)
1/13
(7.69%)
5/12
(41.67%)
[102] ≥3.0 unspecified 8/46
(17.39%)
. . .
3.0–3.9 unspecified 4/35
(11.43%)
. . .
4.0–4.9 unspecified 2/7
(28.57%)
. . .
5.0–5.9 unspecified 1/3
(33.33%)
. . .
≥6.0 unspecified 1/1
(100.00%)
. . .
[72] 3.5–4.4 unspecified . 4/343
(1.17%)
. .
4.5–5.4 unspecified . 3/124
(2.42%)
. .
5.5–6.4 unspecified . 4/73
(5.48%)
. .
≥6.5 unspecified . 0/59
(0.00%)
. .
[73] ≥99ct unspecified 94/221
(42.53%)
1/106
(0.94%)
. .
[74] ≥3.0 apparently isolated 21/108
(19.44%)
9/87
(10.34%)
. .
3.0–3.9 apparently isolated 12/81
(14.81%)
6/69
(8.70%)
. .
≥4.0 apparently isolated 9/27
(33.33%)
3/18
(16.67%)
. .
[75] ≥3.0 unspecified 172/775
(22.19%)
4/256
(1.56%)
. .
[76] ≥3.5 apparently isolated . 1/172
(0.58%)
. .
[77] 95ct–3.4 unspecified 507/7109
(7.13%)
. . .
3.5–4.4 unspecified 423/2101
(20.13%)
. . .
4.5–5.4 unspecified 321/707
(45.40%)
. . .
5.5–6.4 unspecified 219/437
(50.11%)
. . .
6.5–7.4 unspecified 218/309
(70.55%)
. . .
7.5–8.4 unspecified 148/209
(70.81%)
. . .
8.5–9.4 unspecified 126/168
(75.00%)
. . .
9.5–10.4 unspecified 74/88
(84.09%)
. . .
10.5–11.4 unspecified 45/64
(70.31%)
. . .
≥11.5 unspecified 87/123
(70.73%)
. . .
[78] ≥3.5 apparently isolated . 3/269
(1.12%)
. .
≥3.5 associated . 3/31
(9.68%)
. .
[79] ≥6.5 unspecified 60/84
(71.43%)
. . .
5.5–6.4 unspecified 21/37
(56.76%)
. . .
[80] ≥3.5 unspecified 164/303
(54.13%)
. . .
[81] ≥3.5 unspecified 123/222
(55.41%)
. . .
≥3.5 apparently isolated 32/107
(29.91%)
. . .
≥3.5 associated 91/115
(79.13%)
. . .
[82] ≥95ct unspecified 154/393
(39.19%)
. . .
95ct–3.4 unspecified 31/170
(18.24%)
. . .
3.5–4.4 unspecified 29/81
(35.80%)
. . .
4.5–5.4 unspecified 23/42
(54.76%)
. . .
5.5–6.4 unspecified 15/23
(65.22%)
. . .
≥6.5 unspecified 56/77
(72.73%)
. . .
[83] ≥95ct unspecified 37/186
(19.89%)
. . .
95ct–3.4 unspecified 10/92
(10.87%)
. . .
3.5–4.4 unspecified 6/50
(12.00%)
. . .
4.5–5.4 unspecified 4/12
(33.33%)
. . .
5.5–6.4 unspecified 7/15
(46.67%)
. . .
≥6.5 unspecified 10/17
(58.82%)
. . .
[84] 2.5–4.4 unspecified 29/33
(87.88%)
. . .
4.5–6.4 unspecified 8/8
(100.00%)
. . .
≥6.5 unspecified 11/13
(84.62%)
. . .
[85] ≥99ct unspecified 64/248
(25.81%)
. . .
[86] ≥4.0 unspecified 71/160
(44.38%)
. . .
[87] ≥6.5 unspecified 89/120
(74.17%)
. . .
[88] ≥95ct unspecified 44/147
(29.93%)
. . .